International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
A Comparative Study of Diane?35 plus Spironolactone and Diane ?35 Plus Finasteride in Cases of Hirsutism and Acne
Authors
Abstract
To compare the efficacy and safety of Diane 35 plus spironolactone and Diane 35 plus finasteride in the treatment of hirsutism and acne. Materials and Methods: A prospective randomized clinical trial was conducted on 120 Indian women with hirsutism. Group I patients were treated with Diane 35 plus spironolactone 100 mg daily and group II patients with Diane 35 plus finasteride 5 mg daily for 12 months. Hirsutism and acne score were graded every 3 months, for 18 months. The basal gonadotropins levels and androgens level were measured before the study. Statistical analysis was done by Student‘s t-test and repeated measure analysis followed by post hoc comparison. Results: Reduction in hirsutism and acne scores assessed every 3 months was significant (p<0.001) and similar between the two groups, indicating that if treatment was prolonged for over 12 months, reduction scores would have been better. A significant decrease in the hirsutism score of 55.3%±17.2 and 59.4%±17.5 was observed after 12 months in groups I and II respectively. Total reduction in hirsutism & acne scores of both groups was similar (P>0.05). Conclusion: Diane 35 plus spironolactone and Diane 35 plus finasteride are equally effective and safe in the treatment of hirsutism and acne. For better outcomes, it is recommended that the treatment period be over 12 months.
Copyright
© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Oral Pulse Betamethasone, Methotrexate, and Combination Therapy to Treat Severe Alopecia Areata: A Randomized, Double-blind, Placebo-controlled, Clinical Trial
Asilian A, Fatemi F, Ganjei Z, Siadat AH, Mohaghegh F, et al. Oral Pulse Betamethasone, Methotrexate, and Combination Therapy to Treat Severe Alopecia Areata: A Randomized, Double-blind, Placebo-controlled, Clinical Trial. Iran J Pharm Res. 2021;20(1):e124354. doi: https://doi.org/10.22037/ijpr.2020.113868.14536
A Randomized, Double-blind Controlled Clinical Study to Evaluate the Efficacy and Safety of Minoxidil Topical 2% Nanosuspension with Aqueous Base in the Treatment of Androgenetic Alopecia Areata
Mirzaeei S, Barfar A, Mehrandish S, Ebrahimi A. A Randomized, Double-blind Controlled Clinical Study to Evaluate the Efficacy and Safety of Minoxidil Topical 2% Nanosuspension with Aqueous Base in the Treatment of Androgenetic Alopecia Areata. J Rep Pharm Sci. 2021;10(2):e146965. doi: https://doi.org/10.4103/jrptps.JRPTPS_25_21
Comparing the Efficacy of add-on Nortryptiline With Triiodothyronine in the Management of Citalopram-Resistant Depression
Mokhber N, Talaei A. Comparing the Efficacy of add-on Nortryptiline With Triiodothyronine in the Management of Citalopram-Resistant Depression. Iran J Psychiatry Behav Sci. 2007;1(2):. doi:
Comparison of acid salisylic 2% and betamethasone with topical fish oil in recovery of psoriasis signs
Ghaderi R, Madar Shahian F. Comparison of acid salisylic 2% and betamethasone with topical fish oil in recovery of psoriasis signs. J Inflamm Dis. 2024;8(2):e155043. doi:
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 0
Last Update: 1 month ago
- Scopus by Title (Ref): 0
Last Update: 1 month ago
- CrossRef: 0
Last Update: 23 hours ago